CK
Chanda Kumari
About Chanda Kumari
Data last updated:
Chanda Kumari is a Director at Xenas Pharma (Opc) Private Limited (since 2024). The companies operate in Paper and Professional Services. Earlier, Chanda Kumari was an Additional Director at Astrardent Laboratories Private Limited (2019–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Jun 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 27 Jun 2019 | 2018 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Chanda Kumari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anish Singh Kumar | 08232371 | Xenas Pharma (Opc) Private Limited | Nominee |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chanda Kumari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chanda Kumari
Chanda Kumari currently holds 1 directorship: Xenas Pharma (Opc) Private Limited (Director, since 14 Jun 2024).
Chanda Kumari was first appointed on 27 Jun 2019 as Additional Director at Astrardent Laboratories Private Limited. The most recent appointment on record is 14 Jun 2024 at Xenas Pharma (Opc) Private Limited.
Chanda Kumari held 1 earlier board appointment: Astrardent Laboratories Private Limited (Additional Director, 27 Jun 2019 to 27 Sep 2022).
The current boards of Chanda Kumari's companies include Anish Singh Kumar (Xenas Pharma (Opc) Private Limited).